Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexmedetomidine for prevention of acute kidney injury in children undergoing open-heart surgery for congenital heart disease
IRCT20130816014372N10Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Cardiovascular Malformation (CVM) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Serum creatinine and Glomerular filtration rate. Started May 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on IRCT20130816014372N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130816014372N10.